nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A ferritin nanoparticle vaccine for foot-and-mouth disease virus elicited partial protection in mice
|
Chen, Yibao |
|
|
38 |
35 |
p. 5647-5652 |
artikel |
2 |
‘Alternative abridged preventive regimens against rabies for children in high endemic countries’
|
Soentjens, Patrick |
|
|
38 |
35 |
p. 5578-5579 |
artikel |
3 |
Are unexplained adverse health events following HPV vaccination associated with infectious mononucleosis? – A Danish nationwide matched case-control study
|
Krogsgaard, Lene Wulff |
|
|
38 |
35 |
p. 5678-5684 |
artikel |
4 |
Bacillus Calmette–Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality
|
Osama El-Gendy, Ahmed |
|
|
38 |
35 |
p. 5564-5568 |
artikel |
5 |
DNA vaccination with the Mycobacterium marinum MMAR_4110 antigen inhibits reactivation of a latent mycobacterial infection in the adult Zebrafish
|
Niskanen, Mirja |
|
|
38 |
35 |
p. 5685-5694 |
artikel |
6 |
Do parasite infections interfere with immunisation? A review and meta-analysis
|
Wait, Liana F. |
|
|
38 |
35 |
p. 5582-5590 |
artikel |
7 |
Dynamics of G2P[4] strain evolution and rotavirus vaccination: A review of evidence for Rotarix
|
Bibera, Gyneth Lourdes |
|
|
38 |
35 |
p. 5591-5600 |
artikel |
8 |
Editorial Board/Aims and Scope
|
|
|
|
38 |
35 |
p. IFC |
artikel |
9 |
Epitope-based sieve analysis of Plasmodium falciparum sequences from a FMP2.1/AS02A vaccine trial is consistent with differential vaccine efficacy against immunologically relevant AMA1 variants
|
Ouattara, Amed |
|
|
38 |
35 |
p. 5700-5706 |
artikel |
10 |
Ethics of a partially effective dengue vaccine: Lessons from the Philippines
|
Halstead, Scott B. |
|
|
38 |
35 |
p. 5572-5576 |
artikel |
11 |
Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reactive vaccination
|
Soeters, Heidi M. |
|
|
38 |
35 |
p. 5726-5733 |
artikel |
12 |
Evidence of HPV vaccination efficacy comes from more than clinical trials
|
Sasieni, Peter |
|
|
38 |
35 |
p. 5569-5571 |
artikel |
13 |
Expression of concern: “Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?” and “Bactericidal antibody against a representative epidemiological meningococcal serogroup”
|
Poland, Gregory A. |
|
|
38 |
35 |
p. 5577 |
artikel |
14 |
Impact of rotavirus vaccination on intussusception hospital admissions in England
|
McGeoch, Luke J. |
|
|
38 |
35 |
p. 5618-5626 |
artikel |
15 |
Isotype-specific outcomes in Fc gamma receptor targeting of PspA using fusion proteins as a vaccination strategy against Streptococcus pneumoniae infection
|
Wiedinger, Kari |
|
|
38 |
35 |
p. 5634-5646 |
artikel |
16 |
Pneumococcal vaccination in older adults: An initial analysis of social determinants of health and vaccine uptake
|
Gatwood, Justin |
|
|
38 |
35 |
p. 5607-5617 |
artikel |
17 |
Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018–2019
|
Melidou, Angeliki |
|
|
38 |
35 |
p. 5707-5717 |
artikel |
18 |
Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series
|
Oliver, Jennifer L. |
|
|
38 |
35 |
p. 5718-5725 |
artikel |
19 |
Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates
|
Ren, Wenlin |
|
|
38 |
35 |
p. 5653-5658 |
artikel |
20 |
Reply to ‘Alternative abridged preventive regimens against rabies for children in high endemic countries’
|
Trotter, Caroline |
|
|
38 |
35 |
p. 5580-5581 |
artikel |
21 |
Self-reported vaccination status and attitudes towards mandatory vaccinations for health care workers among medical students
|
Kunze, Ursula |
|
|
38 |
35 |
p. 5695-5699 |
artikel |
22 |
Skin thickness in neonates: Implications for intradermal vaccination
|
Saitoh, Akihiko |
|
|
38 |
35 |
p. 5659-5664 |
artikel |
23 |
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines
|
Kochhar, Sonali |
|
|
38 |
35 |
p. 5734-5739 |
artikel |
24 |
To our readers: Important notice
|
Poland, Gregory A. |
|
|
38 |
35 |
p. 5563 |
artikel |
25 |
Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma
|
Yazdani, Mona |
|
|
38 |
35 |
p. 5665-5677 |
artikel |
26 |
Varicella vaccination as useful strategy for reducing the risk of varicella-related hospitalizations in both vaccinated and unvaccinated cohorts (Italy, 2003–2018)
|
Amodio, Emanuele |
|
|
38 |
35 |
p. 5601-5606 |
artikel |
27 |
When being positive might be negative: An analysis of Australian and New Zealand newspaper framing of vaccination post Australia's No Jab No Pay legislation
|
Ashwell, Douglas |
|
|
38 |
35 |
p. 5627-5633 |
artikel |